Is Alzheimer's disease a mitochondrial disorder?

被引:31
|
作者
Cash, AD [1 ]
Perry, G [1 ]
Ogawa, O [1 ]
Raina, AK [1 ]
Zhu, XW [1 ]
Smith, MA [1 ]
机构
[1] Case Western Reserve Univ, Inst Pathol, Cleveland, OH 44106 USA
来源
NEUROSCIENTIST | 2002年 / 8卷 / 05期
关键词
Alzheimer's disease; amyloid-beta; antioxidants; free radicals; mitochondria; neurodegeneration;
D O I
10.1177/107385802236968
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cell bodies of neurons at risk of death in Alzheimer's disease (AD) have increased lipid peroxidation, nitration, free carbonyls, and nucleic acid oxidation. These oxidative changes occur in all vulnerable neurons and are reduced in neurons that contain neurofibrillary pathology. In this review, the authors provide a summary of recent work that demonstrates key abnormalities that may play a part in initiating and promoting neuronal oxidative damage. Mitochondrial abnormalities are clearly involved as a source of reactive oxygen species that culminates in perikaryal oxidative damage. However, because mitochondria in AD do not exhibit striking evidence of oxidative damage, as would be expected if they produced free radicals directly, the authors suspected that abnormal mitochondria are responsible for supplying a key reactant, that once in the cytoplasm, releases radicals. Because abnormal mitochondria, H2O2 and redox-active iron are juxtaposed in the same AD neuron, it has all the markings of a "radical factory." The proximal causes of mitochondrial abnormalities likely involve reentry into the cell cycle, where organellokinesis and proliferation results in an increase of mitochondria and intermediately differentiated cells, with a consequent increase in turnover. Supporting this, the authors have considerable in vivo and in vitro evidence for mitotic disturbances in AD.
引用
收藏
页码:489 / 496
页数:8
相关论文
共 50 条
  • [1] Mitochondrial Disorders in Alzheimer’s Disease
    Vladimir S. Sukhorukov
    Natalia M. Mudzhiri
    Anastasia S. Voronkova
    Tatiana I. Baranich
    Valeria V. Glinkina
    Sergey N. Illarioshkin
    Biochemistry (Moscow), 2021, 86 : 667 - 679
  • [2] Mitochondrial alterations in Alzheimer's disease
    Baloyannis, SI
    Baloyannis, SI
    NEUROBIOLOGY OF AGING, 2004, 25 : S405 - S406
  • [3] Mitochondrial dysfunction in Alzheimer's disease
    D'Alessandro, Maria Clara Bila
    Kanaan, Salim
    Geller, Mauro
    Pratico, Domenico
    Daher, Joao Paulo Lima
    AGEING RESEARCH REVIEWS, 2025, 107
  • [4] MITOCHONDRIAL DYSFUNCTION IN ALZHEIMER'S DISEASE
    Kota, Lakshmi Narayanan
    Nayak, Rashmitha
    Paul, Pradip
    Viswanath, Biju
    Varghese, Mathew
    Jain, Sanjeev
    Purushottam, Meera
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S840 - S841
  • [5] Mitochondrial alterations in Alzheimer's disease
    Baloyannis, Stavros J.
    JOURNAL OF ALZHEIMERS DISEASE, 2006, 9 (02) : 119 - 126
  • [6] Mitochondrial involvement in Alzheimer's disease
    Bonilla, E
    Tanji, K
    Hirano, M
    Vu, TH
    DiMauro, S
    Schon, EA
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS, 1999, 1410 (02): : 171 - 182
  • [7] Mitochondrial function and Alzheimer's disease
    Ojaimi, J
    Byrne, E
    BIOLOGICAL SIGNALS AND RECEPTORS, 2001, 10 (3-4): : 254 - 262
  • [8] Mitochondrial dysfunction and Alzheimer's disease
    Maruszak, Aleksandra
    Zekanowski, Cezary
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2011, 35 (02): : 320 - 330
  • [9] Mitochondrial dysfunction and Alzheimer's disease
    Ghosh, SS
    Miller, S
    Herrnstadt, C
    Fahy, E
    Shinobu, LA
    Galasko, D
    Thal, LJ
    Beal, MF
    Howell, N
    Parker, WD
    Davis, RE
    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES, 1998, 49 : 59 - 66
  • [10] Mitochondrial Disorders in Alzheimer's Disease
    Sukhorukov, Vladimir S.
    Mudzhiri, Natalia M.
    Voronkova, Anastasia S.
    Baranich, Tatiana I.
    Glinkina, Valeria V.
    Illarioshkin, Sergey N.
    BIOCHEMISTRY-MOSCOW, 2021, 86 (06) : 667 - 679